Establishing the protocols for the South Australian Emergency Department Admission Blood Psychoactive Testing (EDABPT) programme for drug surveillance.
designer drug
emergency department
new psychoactive substance
substance abuse detection
toxicology
Journal
Emergency medicine Australasia : EMA
ISSN: 1742-6723
Titre abrégé: Emerg Med Australas
Pays: Australia
ID NLM: 101199824
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
03
12
2020
received:
28
08
2020
accepted:
09
02
2021
pubmed:
14
3
2021
medline:
28
10
2021
entrez:
13
3
2021
Statut:
ppublish
Résumé
ED presentations because of illicit use of psychotropic drugs and pharmaceuticals result in significant medical harm and resource consumption. Patient assessment is complicated by the regular emergence of new psychoactive substances, difficulties associated with their identification and a lack of information about their effects. Here we report the protocol for the Emergency Department Admission Blood Psychoactive Testing (EDABPT) programme, an observational study utilising clinical data capture and definitive drug identification to assess the medical impact and patterns of illicit drug use in the community, and their geographic and temporal fluctuations. The study provides data to an early warning system targeting an improved public health response to emerging drugs of concern. Enrolment of adult patients presenting with suspected illicit drug use occurs at four major EDs in a single urban setting. Clinical and demographic data are collected by treating clinicians. Blood samples are collected at presentation and frozen on site prior to transport to a specialised forensic facility for comprehensive toxicological screening. Results are fed back to clinicians and disseminated more broadly via an existing local early warning system. Targeted warnings and public health releases are instigated where heightened risk or harm is identified. The study pairs city-wide patient enrolment with analytically confirmed toxicology results to allow broad sampling and identification of illicit drugs causing medical harm. It provides a mechanism for the identification of new agents as they emerge in the community, delivers a relevant and reliable source of information for public health agencies and clinicians and supplements existing local early warning mechanisms.
Identifiants
pubmed: 33713558
doi: 10.1111/1742-6723.13752
doi:
Substances chimiques
Illicit Drugs
0
Psychotropic Drugs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
883-887Informations de copyright
© 2021 Australasian College for Emergency Medicine.
Références
United Nations Office on Drugs and Crime. UNODC Early Warning Advisory on New Psychoactive Substances. 2020. [Cited 29 Jul 2020.] Available from URL: https://www.unodc.org/LSS/Page/NPS
Victorian Department of Justice and Community Safety. National Coronial Information System. [Cited 29 Jul 2020.] Available from URL: https://www.ncis.org.au/
Australian Criminal Intelligence Commission. Illicit Drug Data Report 2017-2018. 2019. [Cited 29 Jul 2020.] Available from URL: https://www.acic.gov.au/publications/illicit-drug-data-report/illicit-drug-data-report-2018-19
Peacock A, Uporova J, Karlsson A et al. Australian Drug Trends 2019: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews. 2019. [Cited 29 Jul 2020.] Available from URL: https://ndarc.med.unsw.edu.au/RESOURCE/KEY-FINDINGS-2019-NATIONAL-ILLICIT-DRUG-REPORTING-SYSTEM-IDRS-INTERVIEWS
Peacock A, Karlsson A, Uporova J et al. Australian Drug Trends 2020: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews. 2020. [Cited 29 Jul 2020.] Available from URL: https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2020-key-findings-national-ecstasy-and-related-drugs-reporting
Australian Criminal Intelligence Commission. National Wastewater Drug Monitoring Program-Report 10. 2020. [Cited 29 Jul 2020.] Available from URL: https://www.acic.gov.au/publications/national-wastewater-drug-monitoring-program-reports
Wood DM, Conran P, Dargan PI. ICD-10 coding: poor identification of recreational drug presentations to a large emergency department. Emerg. Med. J. 2011; 28: 387-9.
Shah A, Wood D, Dargan P. Survey of ICD-10 coding of hospital admissions in the UKdue to recreational drug toxicity. Int. J. Med. 2011; 104: 779-84.
McGrew KM, Homco JB, Garwe T et al. Validity of international classification of diseases codes in identifying illicit drug use target conditions using medical record data as a reference standard: a systematic review. Drug Alcohol Depend. 2020; 208: 107825.
Wood DM, De La Rue L, Hosin AA et al. Poor identification of emergency department acute recreational drug toxicity presentations using routine hospital coding systems: the experience in Denmark, Switzerland and the UK. J. Med. Toxicol. 2019; 15: 112-20.
Di Rico R, Nambiar D, Stoové M, Dietze P. Drug overdose in the ED: a record linkage study examining emergency department ICD-10 coding practices in a cohort of people who inject drugs. BMC Health Serv. Res. 2018; 18: 945.
World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems, 10th Revision. 2020. [Cited 29 Jul 2020.] Available from URL: https://www.who.int/classifications/icd/icdonlineversions/en/
Helander A, Bäckberg M, Hultén P, Al-Saffar Y, Beck O. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci. Int. 2014; 243: 23-9.
Hill SL, Najafi J, Dunn M et al. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification of Novel psychoActive substances (IONA) study. Clin. Toxicol. 2016; 54: 638-43.
McCutcheon D, Raghavan M, Soderstrom J et al. An early warning system for emerging drugs of concern in the emergency department: protocol for the Western Australian illicit substance evaluation (WISE) study. Emerg. Med. Australas. 2019; 31: 411-6.
Monte AA, Hopkinson A, Saben J et al. The psychoactive surveillance consortium and analysis network (PSCAN): the first year. Addiction 2020; 115: 270-8.